The mechanisms responsible for transepithelial Ca2+ and Mg2+ transport in the isolated perfused cortical thick ascending limb (cTAL) of Henle’s loop of the mouse nephron were investigated by measuring transepithelial voltages (PDte) and transepithelial ion net fluxes (JNa, Jc1, Jĸ, Jca, JMg) by electron microprobe analysis. In the presence of furosemide (10-4 mol·l-1, lumen) and diphenylamine-2-carboxylate (DPC, 10-4 mol·l-1, bath), known inhibitors of NaCl reabsorption in the TAL, Ca2+ and Mg2+ reabsorption was completely inhibited. In the presence of furosemide, JCa fell from 0.75 ± 0.07 to -0.08 ± 0.09 pmol·min-1.mm-1 (n = 5) and JMg from 0.47 ± 0.04 to -0.01 ± 0.11 pmol·min-1.mm-1 (n = 5). In the presence of DPC, JCa fell from 0.57 ± 0.08 to -0.07 ± 0.11 pmol·min-1.mm-1 (n = 5), and JMg from 0.16 ± 0.02 to-0.11 ± 0.07pmol·min-1·mm-1(n = 5). With furosemide, inhibition of Ca2+ and Mg2+ transport was paralleled by a 93% inhibition of NaCl reabsorption, while in the presence of DPC there was a 60% reduction of NaCl reabsorption. These effects were fully reversed after removal of the inhibitors from the lumen or bath solutions. In the absence of active NaCl transport, a lumen-to-bath directed-NaCl gradient (lumen: 150 mM NaCl + furosemide, bath: 50 mM NaCl + 200 mM mannitol) generated a negative transepithelial dilution potential of-13.8 ± 1.1 mV (n = 8) which induced a significant Ca2+ and Mg2+ secretion into the tubular lumen of -0.59 ± 0.06 and 0.43 ± 0.05pmol·min-1·mm-1 (n = 8), respectively. Abath-to-lumen-directed NaCl gradient on the other hand (lumen: 50 mM NaCl + furosemide, bath: 150mM NaCl) generated a positive transepithelial dilution potential of +15.9 ± 0.6 mV (n = 7), inducing a significant Ca2+ and Mg2+ reabsorption of 0.62 ± 0.08 and 0.38 ± 0.07 pmol·min-1 mm-1(n = 7), respectively. Linear regression analysis of individual Ca2+ and Mg2+ net flux data versus voltage indicated that JCa and JMg were highly correlated to PDte. In conclusion, these data indicate that transepithelial Ca2+ and Mg2+ reabsorption in the mouse cTAL is predominantly a passive process, driven by the lumen-positive PDte.

Keywords:
Ca2+ transport, Diphenylamine-2-carboxylate, Electron microprobe, Cortical thick ascending limb, Furosemide, Mg2+ transport, Passive permeability
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.